Fairvalue-Calculator Fairvalue-Calculator
EN DE

Zhejiang Yatai Pharmaceutical Co (002370) Fair Value & Analysis

Healthcare · CN · Market cap 3.8B CNY

Price¥4.92
Fair Value¥1.42
Upside-71.1%
Quality95/100
Evidence: High Range ¥1.25 – ¥1.90

Analysis

Zhejiang Yatai Pharmaceutical Co (002370) currently trades at ¥4.92, while our model-based Fair Value estimate is ¥1.42 — implying the stock looks roughly 71.1% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers solid dosage, cephalosporin powder injection, and freeze-dried powder injection products. It also provides various antibiotic and non-antibiotic drugs. The company was founded in 1989 and is based in Shaoxing, China.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +1827% Jiangsu Hengrui Pharmaceuticals Co (600276) -43% Sun Pharmaceutical Industries Limited (SUNPHARMA) -49% Zoetis Inc (Z1TS34) -24% Hansoh Pharmaceutical Group (3692) -18% Divi's Laboratories Limited (DIVISLAB) -81%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.